查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1687743

全球空胶囊市场占有率分析、产业趋势与统计、成长预测（2025-2030）

Global Empty Capsules - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计预测期内全球空胶囊市场将以 7.4% 的复合年增长率成长。

全球空心胶囊市场-IMG1

预计 COVID-19 疫情将对市场成长产生正面影响。增强免疫力对于抵抗病毒感染至关重要，因此对天然草药和膳食补充剂形式的免疫力增强剂的需求正在上升。除了基本的卫生习惯外，良好的饮食和生活习惯对于预防和治疗 COVID-19 等呼吸道病毒性疾病也至关重要。根据2020年发表的一篇研究论文，所有COVID-19患者入院时都应接受营养不良筛检，并评估其血清维生素D浓度。此外，2020 年 3 月，Stabilitech BioPharma Ltd 开发了一种用于接种 COVID-19 疫苗的新型口服胶囊。因此，COVID-19 疫情正在推动对膳食补充剂的需求，预计这将推动市场成长。

推动市场成长的关键因素包括胶囊相对于其他药物输送形式越来越受欢迎，以及空胶囊供应商和明胶製造商之间战略联盟的日益加强。此外，全球老龄人口数量的不断增长也推动了对一系列治疗和营养补充剂的需求，以实现更好的健康结果。根据联合国《世界老化：2020 年修订版》预测，到 2050 年，年龄在 65 岁或以上的人口将达到 15 亿左右，高于 2020 年的 7.27 亿。此外，胶囊输送技术的快速进步预计将促进市场成长。然而，道德问题、明胶材料的价格波动以及製药业的严格监管预计将阻碍市场成长。

空胶囊的市场趋势

心血管治疗领域预计将在预测期内实现健康的复合年增长率

心血管疾病（CVD）在全球十分普遍。根据世界卫生组织（WHO）2019年的数据，全球每年约有1,790万人死于心血管疾病，预计2030年将增加至2,360万以上。此外，根据美国心臟协会2020年的研究报告，被列为根本死因的心血管疾病在美国每天约造成2,353人死亡，平均每37秒就有一人死亡。此外，根据英国心臟基金会中心 2021 年的数据，英国约有 760 万人患有心臟和循环系统疾病。英国每年有超过 40,000 名 75 岁以下的人死于心臟和循环系统疾病。全球心血管疾病的高发生率刺激了对有效治疗心血管疾病疗法的需求，从而推动了市场的成长。

此外，在COVID-19疫情期间，美国心臟病学会和加拿大心血管学会发布了重新引入心臟服务的指南，包括家庭心臟康復，提供运动训练和饮食咨询、药物管理、戒烟咨询和心理社会评估干预。因此，预计心臟復健课程的增加将促进 COVID-19 大流行期间的学习发展。

此外，2019年9月，鲁宾公司获得加拿大卫生监管机构核准，可生产用于治疗高血压和减少心绞痛发作频率的Propranolol普萘洛尔缓释胶囊。预测期内，产品核可的增加预计也将推动此领域的发展。

空胶囊可以有效遮罩心臟病药物的味道，防止患者感到噁心。因此，随着心血管疾病盛行率的增加，对心臟照护的需求也随之增加。这项因素可能会对空胶囊市场产生正面影响。

北美占据了大部分市场份额，预计在预测期内将继续保持这一地位。

由于人们对胶囊型营养保健品配方的偏好日益增长，预计该地区将占据相当大的份额。这些膳食补充剂的消费量正在上升，因为它们有助于预防肥胖、癌症和关节炎等重大健康问题。此外，由于胶囊是最受欢迎的固态口服剂型，该地区的膳食补充剂行业对空胶囊的需求很高。

此外，美国慢性病负担加重以及老年人口增加也被认为是北美市场成长的主要因素。根据《美国人口老化公报》，预计到 2060 年，65 岁及以上美国的数量将几乎翻一番，从 2018 年的 5,200 万人增加到 9,500 万人。同样，根据 CRN 2019 年膳食补充剂消费者调查报告，77% 的美国人表示他们服用膳食补充剂。调查也发现，维生素和矿物质是2019年美国最常消费的补充剂，占膳食补充剂总消费量的76%，其次是特种补充剂（40%）、草药和植物药（39%）、运动营养补充剂（28%）和体重管理补充剂（17%）。

然而，在新冠疫情期间，大多数肉类加工厂都关闭了，限制了明胶的供应。此外，由于世界各地边境的运输限制，北美的明胶胶囊供应链预计将受到严重影响，这将阻碍该地区的市场成长。

此外，美国和加拿大已经开发并建立了鼓励研发的医疗保健体系。此外，美国和加拿大正在鼓励全球公司进入该市场。因此，这些国家拥有许多全球市场参与企业。由于该地区跨国公司满足了高需求，预计市场在预测期内将进一步成长。

空胶囊产业概况

主要企业生产大部分空胶囊。拥有更多研究资金和更好分销系统的市场领导正在市场上站稳脚跟。空胶囊市场高度整合，由几家主要参与企业组成，包括 ACG Worldwide、Medi-Caps Ltd、LonzaGroup (Capsugel)、Capscanada Corporation 和 Bright Pharma Caps Inc. 此外，亚太地区对空胶囊的认识不断提高，导致了一些中小型企业的出现。此外，主要企业参与策略联盟和产品发布，以确保其在竞争激烈的市场中的地位。例如，2020年10月，龙沙向其胶囊和健康成分（CHI）部门投资8,500万瑞士法郎，以将其胶囊生产能力扩大至每年300亿粒胶囊。

其他福利

  • Excel 格式的市场预测 (ME) 表
  • 3个月的分析师支持

目录

第一章 引言

  • 研究假设和市场定义
  • 研究范围

第二章调查方法

第三章执行摘要

第四章 市场动态

  • 市场概览
  • 市场驱动因素
    • 增加药物用途
    • 空胶囊的技术进步
    • 老年人口不断增加
  • 市场限制
    • 明胶价格上涨，原料取得困难
    • 文化习俗和饮食限制
  • 波特五力分析
    • 新进入者的威胁
    • 买家/消费者的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争对手之间的竞争强度

第五章市场区隔

  • 按产品
    • 明胶胶囊
    • 非明胶胶囊
  • 功能
    • 即时释胶囊
    • 缓释性胶囊
    • 缓释性胶囊
  • 按治疗用途
    • 抗生素和抗菌药物
    • 维生素和营养补充剂
    • 制酸剂和肠道调节剂
    • 心血管治疗
    • 其他的
  • 按最终用户
    • 製药业
    • 营养保健品产业
    • 化妆品产业
    • 研究所
  • 按地区
    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 义大利
      • 西班牙
      • 其他欧洲国家
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳洲
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会国家
      • 南非
      • 其他中东和非洲地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地区

第六章竞争格局

  • 公司简介
    • ACG Worldwide
    • Bright Pharma Caps Inc.
    • Capscanada Corporation
    • Lonza Group（Capsugel）
    • Medi-Caps Ltd
    • Qualicaps
    • Suheung Capsule Co. Ltd
    • Qingdao Yiqing Medicinal Capsules Co. Ltd
    • Shanxi Guangsheng Medicinal Capsules Co. Ltd
    • Healthcaps India Ltd
    • Nectar Lifesciences Ltd
    • Shanxi JC Biological Technology Co. Ltd

第七章 市场机会与未来趋势

简介目录
Product Code: 64988

The Global Empty Capsules Market is expected to register a CAGR of 7.4% during the forecast period.

Global Empty Capsules - Market - IMG1

The COVID-19 pandemic is expected to positively impact the market's growth. As the development of strong immunity plays a vital role in fighting against viral infection, there has been an increasing demand for immunity boosters in the form of natural herbs and nutraceuticals. Apart from the basic hygienic practices, proper dietary and lifestyle behaviors are essential for preventing and treating respiratory viral diseases, such as COVID-19. As per the research article published in 2020, every COVID-19 patient should be screened for malnutrition on admission and assessed for serum vitamin D levels. Additionally, in March 2020, Stabilitech BioPharma Ltd developed a new oral capsule to deliver the COVID-19 vaccine. Thus, the COVID-19 pandemic is boosting the demand for nutraceuticals, which is expected to help the market to grow.

The key factors that boost the market's growth include a rise in the popularity of capsules over other drug delivery forms and an increase in strategic collaborations between empty capsule suppliers and gelatin manufacturers. Also, the growing geriatric population worldwide increases the demand for various therapy drugs and dietary supplements for better health outcomes. According to the United Nations, World Ageing Population: the 2020 Revision, by 2050, approximately 1.5 billion people are likely to be over 65 years, up from 727 million in 2020. In addition, rapid advancements in capsule delivery technologies are set to supplement the market's growth. However, ethical concerns, price fluctuations regarding gelatin materials, and stringent regulations in the pharmaceutical industry are expected to hamper the market growth.

Empty Capsules Market Trends

The Cardiovascular Therapy Drugs Segment is Expected to Witness a Healthy CAGR Over the Forecast Period

Cardiovascular diseases (CVD) are highly prevalent globally. According to the World Health Organization 2019, an estimated 17.9 million people die due to cardiovascular diseases worldwide each year, and the number is expected to grow to more than 23.6 million by 2030. Additionally, as per the American Heart Association Research Report 2020, cardiovascular disease, listed as the underlying cause of death, accounts for nearly 2,353 deaths daily in the United States, which is an average of 1 death every 37 seconds. Also, according to the British Heart Foundation Centre, 2021, around 7.6 million people were living with heart and circulatory diseases in the United Kingdom. More than 40,000 people under the age of 75 years in the United Kingdom die from heart and circulatory diseases each year. The high incidence of cardiovascular diseases worldwide surges the demand for cardiovascular therapy drugs for effective treatment, thus driving the market's growth.

Additionally, during the COVID-19 pandemic, the American College of Cardiology and the Canadian Cardiovascular Society issued guidelines for the reintroduction of cardiac services, including home-based cardiac rehabilitation that provide exercise training and dietary counseling, medication management, tobacco cessation counseling, and psychosocial assessment interventions. Hence, the increasing cardiac rehabilitation sessions are expected to boost the studied segment during the COVID-19 pandemic.

Also, in September 2019, Lupin received approval from the Canadian health regulator for its Propranolol Hydrochloride extended-release capsules used to treat hypertension and decreased frequency of angina. The increasing product approvals are also expected to boost the segment over the forecast period.

Empty capsules are useful in masking the taste of cardiac therapy drugs, which prevents the patient from feeling nauseated. Hence, as the prevalence of CVDs increases, the demand for cardiac therapy drugs will also increase. This factor may positively impact the empty capsules market.

North America Holds a Significant Share in the Market and is Expected to Continue the Trend over the Forecast Period

The region holds a major share due to the rising preference for capsule-based nutraceutical formulations. Since these nutraceuticals help prevent major health problems, such as obesity, cancer, and arthritis, their consumption has increased. Additionally, capsules are the most preferred solid oral dosage forms, and thus, the demand for empty capsules in the nutraceutical industry is high in the region.

Also, the growing burden of chronic diseases, along with the rising geriatric population in the United States, is considered a major factor for the growth of the market in North America. According to the Population Reference Bureau's Population Bulletin-Aging in the United States, the number of Americans aged 65 years and older is projected to nearly double from 52 million in 2018 to 95 million by 2060. Similarly, as per the CRN Consumer Survey on Dietary Supplements, 2019 report, 77% of Americans reported consuming dietary supplements. Also, the survey revealed that vitamins and minerals were the most common supplements consumed by the American population in 2019, accounting for 76% of total dietary supplement consumption, followed by specialty supplements (40%), herbals and botanicals (39%), sports nutrition supplements (28%), and weight management supplements (17 %) in 2019.

However, during the COVID-19 pandemic, most meat processing facilities were shut down, which limited the availability of gelatin. Additionally, due to the transport restrictions in the borders of various countries worldwide, North America is expected to be severely impacted on the supply chain of the gelatin capsule, which is expected to hamper the market's growth in the region.

Moreover, the United States and Canada have a developed and well-structured healthcare system, which encourages research and development. They also encourage global players to enter the United States and Canada. As a result, these countries enjoy the presence of many global market players. As the high demand is met by the presence of global players in the region, the market is further expected to grow over the forecast period.

Empty Capsules Industry Overview

Global key players are manufacturing the majority of empty capsules. Market leaders with more funds for research and a better distribution system have established their positions in the market. The empty capsules market is highly consolidated and consists of a few major players, including ACG Worldwide, Medi-Caps Ltd, LonzaGroup (Capsugel), Capscanada Corporation, and Bright Pharma Caps Inc. Moreover, Asia-Pacific is witnessing the emergence of a few small- and medium-sized players due to the rising awareness of empty capsules. Additionally, key players are involved in strategic alliances and product launches to secure their positions in the competitive market. For instance, in October 2020, Lonza invested CHF 85 million in its Capsules and Health Ingredients (CHI) division to expand its capsule manufacturing capacity by 30 billion capsules annually.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Pharmaceutical Applications
    • 4.2.2 Technological Advancements in Empty Capsules
    • 4.2.3 Growing Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 Rising Gelatin Prices and Lower Availability of Raw Materials
    • 4.3.2 Cultural Practices and Dietary Restrictions
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Gelatin Capsules
    • 5.1.2 Non-gelatin Capsules
  • 5.2 By Functionality
    • 5.2.1 Immediate-release Capsules
    • 5.2.2 Delayed-release Capsules
    • 5.2.3 Sustained-release Capsules
  • 5.3 By Therapeutic Application
    • 5.3.1 Antibiotic and Antibacterial Drugs
    • 5.3.2 Vitamins and Dietary Supplements
    • 5.3.3 Antacid and Antiflatulent Preparations
    • 5.3.4 Cardiovascular Therapy Drugs
    • 5.3.5 Other Therapeutic Applications
  • 5.4 By End User
    • 5.4.1 Pharmaceutical Industry
    • 5.4.2 Nutraceutical Industry
    • 5.4.3 Cosmetics Industry
    • 5.4.4 Research Laboratories
  • 5.5 By Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle-East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 ACG Worldwide
    • 6.1.2 Bright Pharma Caps Inc.
    • 6.1.3 Capscanada Corporation
    • 6.1.4 Lonza Group (Capsugel)
    • 6.1.5 Medi-Caps Ltd
    • 6.1.6 Qualicaps
    • 6.1.7 Suheung Capsule Co. Ltd
    • 6.1.8 Qingdao Yiqing Medicinal Capsules Co. Ltd
    • 6.1.9 Shanxi Guangsheng Medicinal Capsules Co. Ltd
    • 6.1.10 Healthcaps India Ltd
    • 6.1.11 Nectar Lifesciences Ltd
    • 6.1.12 Shanxi JC Biological Technology Co. Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS